Olivier Chinot
奥利维耶·希诺
MD, PhD
Professor of Neurology; Head, Neuro-Oncology Department神经病学教授；神经肿瘤学部负责人
👥Biography 个人简介
Head of Neuro-Oncology at La Timone University Hospital in Marseille and professor at Aix-Marseille University. Led the landmark AVAglio phase III trial of bevacizumab in newly diagnosed GBM, and has driven European neuro-oncology research on anti-angiogenic and systemic therapies.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
AVAglio Trial
Principal investigator of the AVAglio phase III trial adding bevacizumab to Stupp protocol in newly diagnosed GBM, demonstrating improved PFS and quality of life despite no OS benefit.
Anti-Angiogenic Therapy Mechanisms
Characterized vascular normalization, radiographic pseudoresponse, and resistance mechanisms to anti-VEGF therapy in glioma, informing rational combination strategies.
Representative Works 代表性著作
Bevacizumab plus radiotherapy–temozolomide for newly diagnosed glioblastoma
New England Journal of Medicine (2014)
AVAglio phase III trial reporting significantly improved PFS with bevacizumab in newly diagnosed GBM, shaping global practice guidelines.
Quality of life in newly diagnosed glioblastoma patients treated with bevacizumab
Neuro-Oncology (2022)
Long-term quality-of-life analysis from AVAglio demonstrating steroid-sparing and functional benefits of bevacizumab therapy.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 奥利维耶·希诺 的研究动态
Follow Olivier Chinot's research updates
留下邮箱，当我们发布与 Olivier Chinot（La Timone University Hospital, Aix-Marseille University）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment